Suzanne Rivera named new VP for research

Provost W.A. "Bud" Baeslack III announced, on November 4th, the appointment of Suzanne M. Rivera as Case Western Reserve´s new vice president for research, effective this month. Rivera, the university´s associate vice president for research since January 2011, emerged as the top choice after an extensive process involving campuswide nominations of internal university candidates. Since coming to CWRU, Rivera has distinguished herself through a commitment to collaboration and a focus on systems and processes.
Read more about her.


Research Matters

Click here to view previous editions of Research Matters and Research News and Updates.




Latest News

Research Newsletter
December 9, 2014  

The Ohio Clinical Trial Collaborative (OCTC)

The Ohio Clinical Trial Collaborative OCTC is developing partnerships with the drug industry to include Biotech and Pharmaceutical industries to perform clinical drug trials phase I-4. The OCTC is a network of Ohio based hospitals led by working groups in areas such as neuro oncology, pediatrics, infectious disease, and neuroscience. The OCTC was launched at the BIO2014 which was attended by 15,000 biotech and pharmaceutical executives in San Diego resulting in numerous leads for potential drug trials.

The OCTC has plans to attend additional biotech and pharmaceuticals shows. The OCTC is looking for additional working groups interested in developing a sell sheet that can then be searched on the World Wide Web and will begin sales and marketing activities to identify opportunities with industry. If there are companies that individuals would like OCTC to target, the group welcomes that feedback.

Review the OCTC working website at: http://ohioclintrials.org.

Contact Joe Peter at 216-702-5314 for more information.

 
FOIA Requests

CWRU researchers who receive requests for information that invoke the Freedom of Information Act (FOIA) should contact the Office of General Counsel. This should be done immediately so the extremely short deadlines under FOIA can be met. General Counsel can work with the faculty member to take steps to protect proprietary or confidential information from grants and protocols prior to the release of the requested information. Individual researchers should not release information without first consulting with the CWRU Office of General Counsel.

For more information, contact the Office of General Counsel at: http://www.case.edu/president/counsel/contactus.html.

 
The National Academies

The National Academies has announced their 2015 Jefferson Science Fellows (JSF) competition. The Jefferson Science Fellows program, now in its 12th year, was established by the U.S. Secretary of State to engage the American academic science, technology, engineering and medical communities I the design and implementation of U.S. foreign policy.

Jefferson Science Fellows spend one year at the U.S. Department of State or the U.S. Agency for International Development (USAID) for an on-site assignment in Washinton, D.C. that may also involve extended stays at U.S. foreign embassies and/or missions. The fellowship is open to tenured, or similarly ranked, academic scientists, engineers and physicians from U.S. institutions of higher learning who are U.S. citizens.

The application deadline is January 12, 2015, and awardees will be notified in March. Up to fifteen Fellows are expected to be selected for the 2015 program year.

Visit the Jefferson Science Fellowship website for more information on requirements and deadlines.

 

Foundation Fighting Blindness and Harrington Discovery Institute

Foundation Fighting Blindness and Harrington Discovery Institute have partnered to form, the The National Center for Excellence in Fighting Blindness, a Gund-Harrington initiative. This initiative is focused on accelerating the translation of research findings in inherited retinal degenerative diseases (IRD) with the ultimate goal of developing new therapies to improve and/or restore vision.

• This Initiative seeks to award Gund-Harrington Scholar Awards that recognize innovators throughout the USA whose research has the potential to advance standards of care.
• There will be an average of three awards per year, which will be restricted to researchers working at institutions within the USA. Applications from outside the USA are not accepted.
• The Gund-Harrington Scholar Award provides funding for translational drug development and cell therapy along with non-financial project support to help bridge the gap between laboratory-based research and the clinic.
• Funding up to a total of $900,000 over three years and non-financial support will be provided by the The National Center for Excellence in Fighting Blindness. The non-financial support, provided by a team of pharmaceutical experts, will include project management and experienced industry advice in all aspects of drug development, encompassing chemistry, formulation, toxicology, regulatory, intellectual property and business development.
• Awards will be made to physician-scientists, or scientists with a research team that includes significant involvement of a physician with clinical expertise in the IRD.
• Selected projects must demonstrate a reasonable expectation that they can develop a lead product with strong potential for clinical and commercial application by the end of the three year funding period.
Multi-disciplinary investigators outside the field of retinal disease are particularly encouraged to apply.

Applicants interested in the Gund-Harrington Scholar Awards must apply through Foundation Fighting Blindness.

For more information about Foundation Fighting Blindness visit the Fighting Blindness website.

 

Bladder Cancer Advocacy Network (BCAN)

BETHESDA, MD – The Bladder Cancer Advocacy Network (BCAN) is seeking applicants for the 2015 Bladder Cancer Research Innovation Award. The award is generously funded by the James Family Foundation in conjunction with Partner Fund Management. The research program will award one $300,000 two-year grant to an experienced investigator who will break new ground in the field of bladder cancer. The application process is open and letters of intent are due by January 14, 2015.

The Bladder Cancer Research Innovation Award was established in 2014 to support exceptionally novel and creative projects with great potential to produce breakthroughs in the management of bladder cancer. Proposals will be accepted for creative ideas and innovative approaches that have direct application and relevance to bladder cancer.

For more information, go to the Bladder Cancer Advocacy website or contact BCAN at 301-215-9099.

 

If you have news or information that you wish to have included in this update, please send it via e-mail to Tracy Wilson-Holden at tracy.wilson-holden@case.edu no later than 5 pm on the Monday of the week that the update is to be distributed. If you know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe to Case Research News, email your request to Tora Williams at tora.williams@case.edu.

Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not move or be deleted.